These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 12082591

  • 21. P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth.
    Drozdzik M, Mysliwiec K, Lewinska-Chelstowska M, Banach J, Drozdzik A, Grabarek J.
    J Clin Periodontol; 2004 Sep; 31(9):758-63. PubMed ID: 15312098
    [Abstract] [Full Text] [Related]

  • 22. Reduced cardio-respiratory coupling after treatment with nortriptyline in contrast to S-citalopram.
    Bär KJ, Schuhmacher A, Höfels S, Schulz S, Voss A, Yeragani VK, Maier W, Zobel A.
    J Affect Disord; 2010 Dec; 127(1-3):266-73. PubMed ID: 20538342
    [Abstract] [Full Text] [Related]

  • 23. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population.
    Lakhan R, Misra UK, Kalita J, Pradhan S, Gogtay NJ, Singh MK, Mittal B.
    Epilepsy Behav; 2009 Jan; 14(1):78-82. PubMed ID: 18812236
    [Abstract] [Full Text] [Related]

  • 24. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
    Ejsing TB, Linnet K.
    Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
    [Abstract] [Full Text] [Related]

  • 25. Cardiovascular effects of fluoxetine in depressed patients with heart disease.
    Roose SP, Glassman AH, Attia E, Woodring S, Giardina EG, Bigger JT.
    Am J Psychiatry; 1998 May; 155(5):660-5. PubMed ID: 9585718
    [Abstract] [Full Text] [Related]

  • 26. Use of yohimbine to counteract nortriptyline-induced orthostatic hypotension.
    Seibyl JP, Krystal JH, Price LH, Charney DS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):67-8. PubMed ID: 2708559
    [No Abstract] [Full Text] [Related]

  • 27. Tricyclic-induced electroencephalogram abnormalities and plasma drug concentrations.
    Preskorn SH, Othmer SC, Lai CW, Othmer E.
    J Clin Psychopharmacol; 1984 Oct; 4(5):262-4. PubMed ID: 6436340
    [Abstract] [Full Text] [Related]

  • 28. Investigation of serotonin-related genes in antidepressant response.
    Peters EJ, Slager SL, McGrath PJ, Knowles JA, Hamilton SP.
    Mol Psychiatry; 2004 Sep; 9(9):879-89. PubMed ID: 15052272
    [Abstract] [Full Text] [Related]

  • 29. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.
    Tufan A, Babaoglu MO, Akdogan A, Yasar U, Calguneri M, Kalyoncu U, Karadag O, Hayran M, Ertenli AI, Bozkurt A, Kiraz S.
    J Rheumatol; 2007 Jul; 34(7):1540-4. PubMed ID: 17610314
    [Abstract] [Full Text] [Related]

  • 30. alpha1-acid glycoprotein in late-life depression: relationship to medical burden and genetics.
    Adeoye OM, Ferrell RE, Kirshner MA, Mulsant BH, Seligman K, Begley AE, Reynolds CF, Pollock BG.
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):235-9. PubMed ID: 14653433
    [Abstract] [Full Text] [Related]

  • 31. Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
    Vandel P, Haffen E, Nezelof S, Broly F, Kantelip JP, Sechter D.
    Hum Psychopharmacol; 2004 Jul; 19(5):293-8. PubMed ID: 15252821
    [Abstract] [Full Text] [Related]

  • 32. Fluoxetine (prozac) in depresion of adults.
    Kocur J, Rydzynski Z, Duszyk S, Gruszczynski W, Trendak W.
    Homeost Health Dis; 1991 Jul; 33(5-6):295. PubMed ID: 18265505
    [No Abstract] [Full Text] [Related]

  • 33. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
    Wong M, Evans S, Rivory LP, Hoskins JM, Mann GJ, Farlow D, Clarke CL, Balleine RL, Gurney H.
    Clin Pharmacol Ther; 2005 Jan; 77(1):33-42. PubMed ID: 15637529
    [Abstract] [Full Text] [Related]

  • 34. Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania.
    De Luca V, Mundo E, Trakalo J, Wong GW, Kennedy JL.
    Pharmacogenomics J; 2003 Jan; 3(5):297-9. PubMed ID: 14583799
    [Abstract] [Full Text] [Related]

  • 35. CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression.
    Murphy GM, Pollock BG, Kirshner MA, Pascoe N, Cheuk W, Mulsant BH, Reynolds CF.
    Neuropsychopharmacology; 2001 Nov; 25(5):737-43. PubMed ID: 11682257
    [Abstract] [Full Text] [Related]

  • 36. High initial nortriptyline doses in the treatment of depression.
    Warner MD, Griffin M, Peabody CA.
    J Clin Psychiatry; 1993 Feb; 54(2):67-9. PubMed ID: 8444823
    [Abstract] [Full Text] [Related]

  • 37. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
    Kok RM, Nolen WA, Heeren TJ.
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
    [Abstract] [Full Text] [Related]

  • 38. Extrapyramidal symptoms associated with the adjunct of nortriptyline to a venlafaxine-valproic acid combination.
    Conforti D, Borgherini G, Fiorellini Bernardis LA, Magni G.
    Int Clin Psychopharmacol; 1999 May; 14(3):197-8. PubMed ID: 10435776
    [Abstract] [Full Text] [Related]

  • 39. Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression.
    Janssen J, Hulshoff Pol HE, Schnack HG, Kok RM, Lampe IK, de Leeuw FE, Kahn RS, Heeren TJ.
    Int J Geriatr Psychiatry; 2007 May; 22(5):468-74. PubMed ID: 17357181
    [Abstract] [Full Text] [Related]

  • 40. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M.
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.